PharmaceuticalfirmAstrazenecaannouncedthepauseofthetrialWednesday,afteroneoftheBritishparticipantsfellillreportedlywithtransversemyelitis.Inflammationofthespinalcord,theparticipantisexpectedtorecover.ThecoronavirusvaccinedevelopedbyAstrazenecaandoxforduniversity,isseenasoneofthemostpromisingofdozensunderdevelopmentaroundtheworld.Aftersuccessfulearlystagetrials,ithadmovedtophase3testinginrecentweeks,involving30,participantsintheUnitedStates,Britain,BrazilandSouthAfrica.Scientistsemphasizedthatthereisnoindicationyetthattheparticipantsillnessislinkedtothevaccine.Youregivingthevaccinetoverylargenumbersofpeople.Andatanygiventimerandomlybychance,itsquitepossiblesomeofthoseparticipantsmayhavehealthproblemsthathappento
本文编辑：佚名
转载请注明出地址 http://www.xiaotongcaoa.com/sltx/12723.html
